The IDM - a cross-faculty, multidisciplinary postgraduate health research institute
Based on the UCT Faculty of Health Sciences campus in a 7,100 sqm state-of-the-art facility, we operate in the fields of infectious diseases and molecular medicine.
Clinical research relevant to the needs of Africa's people
The IDM influences health policy and practice by translating our scientific discoveries and applying them in various communities; community relationships and trust are critical.
Capacity building in the IDM
The largest research entity at UCT, the IDM is a national leader in research and health sciences human capital development.
IDM driving world class research
We conduct research at the laboratory-clinic-community interface by engaging a wide range of scientific and clinical disciplines; with 62 consortia linking us with 183 institutions in 22 African countries and 24 countries beyond.
University accredited research institute - Tackling diseases of importance in Africa - Developing people - Impacting health policy and practice
Three University of Cape Town (UCT) professors have been elected to stand among South Africa’s leading scholars and scientists as members of the Academy of Science of South Africa (ASSAf), while a UCT associate professor joined the ranks of the South African Young Academy of Science (SAYAS).
A new paper by University of Cape Town (UCT) researchers and their international co-authors has explained why patients experiencing unrelenting epileptic seizures, or status epilepticus, stop responding to first-line medication benzodiazepine.
No two people are alike, so why should their medication be? This is the question that drives the work being done by Professor Collet Dandara and his Pharmacogenomics and Drug Metabolism Research Group (PharmGx) at the University of Cape Town (UCT).